Saturday, June 22, 2024 | Baltimore, MD
Baltimore, MD
93°
Sunny
FOLLOW US:

United Therapeutics still eyeing 25K patients by 2025. Here’s what it’ll take to get there.

November 3, 2022
microscope

Silver Spring’s United Therapeutics Corp. (NASDAQ: UTHR) set another revenue record in the third quarter — and with that momentum, is now homing in on its goal to more than double the number of patients currently using its therapies in the next couple of years. For the local biotech, which reported third-quarter earnings Wednesday, growing its patient count from its current 12,000 to 25,000 by 2025 requires “maintaining even half our current growth rate for the next three years,” which seems “eminently doable,” CEO Martine Rothblatt said on a company earnings call Wednesday.

Article Source: Washington Business Joirnal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.